tiprankstipranks
Petros Pharmaceuticals (PTPI)
NASDAQ:PTPI
US Market

Petros Pharmaceuticals (PTPI) Cash flow

91 Followers

Petros Pharmaceuticals Cash Flow

PTPI's free cash flow for Q3 2023 was $-4.05M. For the 2023 fiscal year, PTPI's free cash flow was decreased by $-935.29K and operating cash flow was $-4.05M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -6.96M$ -12.80M$ -11.86M$ -15.31M$ 2.53M
Investing Cash Flow
---$ -4.63K$ -71.54K
Financing Cash Flow
$ 13.73M$ -1.62M$ 18.57M$ 30.30M$ -3.11M
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
$ 45.67M$ 9.43M$ 23.85M$ 17.14M$ 2.15M
Income Tax Paid Supplemental Data
-----
Interest Paid Supplemental Data
$ 555.26K$ 596.02K$ 421.82K$ 1.19M$ 2.04M
Issuance Of Capital Stock
$ 15.00M-$ 21.75M$ 0.00-
Issuance Of Debt
$ -1.27M$ -1.62M$ -6.65M$ 15.50M$ 2.90M
Repayment Of Debt
$ -185.06K$ -1.62M$ -6.65M$ -6.72M$ -6.01M
Free Cash Flow
$ -6.96M$ -12.80M$ -11.86M$ -15.31M$ 2.46M
Domestic Sales
-----
Foreign Sales
-----
Currency in USD

Petros Pharmaceuticals Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis